![](https://www.uspostnews.com/wp-content/uploads/2022/07/17-300x168.jpg)
Trevi Therapeutics Inc (TRVI) is a good investment, but the stock may be undervalued
While Trevi Therapeutics Inc has underperformed by -2.46%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance,